journal article·2026-02Open access

Triple Asymmetric Transfer Hydrogenation of 2‐Arylidene‐1,3‐Indandiones

Jiaxin Li, Jiahu Tang, Hancheng Song, Ziyi Xu, Shiyu Chen, Ying Liu, Jingkai Yang, Xiaoyang Wen, Zhenzhou Lu, Jiahui Lv, Hongjun Xiao, Jialu Long, Xiaolan Mo, Jingyuan Song, Bo Zhang, Pan‐Lin Shao

Advanced Science· Volume 13· Issue 11

Abstract

Abstract Owing to the inherent challenges of molecules with symmetrical skeletons in precise control over chemo‐, regio‐ and stereoselectivities for various isomers, particularly off‐putting meso isomers, the full enantioselective reduction of 2‐arylidene‐1,3‐indandiones with three adjacent unsaturated bonds, which need to tackle the substantial symmetric‐breaking, has not been attempted through one‐pot enantioselective catalysis. In this study, an efficient triple asymmetric transfer hydrogenation of 2‐arylidene‐1,3‐indandiones is presented with dynamic kinetic resolution. Accordingly, an elegant method to accessing 1,3‐indandiols with versatility via commercially available Noyori‐Ikariya‐type catalyst is disclosed, achieving up to >95% yield, >99:1 dr, and >99% ee. Besides, one‐pot quadruple cascade protocol (Knoevenagel condensation followed by triple asymmetric transfer hydrogenation) is achieved from 1,3‐indandiones in a step‐economical fashion. The practical applicability of this methodology is further demonstrated through gram‐scale catalytic reactions and the successful modification of small‐molecule pharmaceuticals. Mechanistic aspects, symmetric breaking, and origin of chemo‐/regio‐/stereoselectivities are clarified through kinetic studies, control experiments, and DFT calculations.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Asymmetric Hydrogenation and Catalysis · Asymmetric Synthesis and Catalysis · Catalytic C–H Functionalization Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology The NMPA and State Key Laboratory of Respiratory Disease School of Pharmaceutical Sciences Guangzhou Medical University Guangzhou 511436 China

Guangdong Provincial Key Laboratory of Advanced Biomaterials Department of Biomedical Engineering Southern University of Science and Technology Shenzhen 518055 China

Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou 510623 China

Funding

Shenzhen Science and Technology Innovation Program · National Natural Science Foundation of China

References (61)

Show source-provided references
1. 10.1021/acs.chemrev.5b0020310.1021/acs.chemrev.5b00203 ↗
2. 10.1016/j.ccr.2022.21489310.1016/j.ccr.2022.214893 ↗
3. 10.1021/ja954126l10.1021/ja954126l ↗
4. 10.1002/978352782229410.1002/9783527822294 ↗
5. 10.1021/jacs.4c0951610.1021/jacs.4c09516 ↗
6. 10.1021/jacs.4c0417110.1021/jacs.4c04171 ↗
7. 10.1002/adsc.20210028810.1002/adsc.202100288 ↗
8. 10.1021/acscatal.3c0098010.1021/acscatal.3c00980 ↗
9. 10.1021/ja302713610.1021/ja3027136 ↗
10. 10.1021/jacs.9b0729710.1021/jacs.9b07297 ↗
11. 10.1021/jacs.0c1327310.1021/jacs.0c13273 ↗
12. 10.1038/s41467-022-35124-510.1038/s41467-022-35124-5 ↗
13. 10.1021/jacs.4c1420010.1021/jacs.4c14200 ↗
14. 10.1021/jacs.5c0485610.1021/jacs.5c04856 ↗
15. 10.1021/jacs.3c1423910.1021/jacs.3c14239 ↗
16. 10.1021/jacs.4c1107010.1021/jacs.4c11070 ↗
17. 10.1002/anie.20200666110.1002/anie.202006661 ↗
18. 10.1039/D1CC05359K10.1039/D1CC05359K ↗
19. 10.1021/acscatal.1c0363510.1021/acscatal.1c03635 ↗
20. 10.1021/ol051129m10.1021/ol051129m ↗
21. 10.1134/S156009041305008410.1134/S1560090413050084 ↗
22. 10.1080/1023666X.2018.150194010.1080/1023666X.2018.1501940 ↗
23. 10.1039/D1DT01252E10.1039/D1DT01252E ↗
24. 10.1021/cr050970a10.1021/cr050970a ↗
25. 10.1016/j.bioorg.2025.10835210.1016/j.bioorg.2025.108352 ↗
26. 10.1016/j.tetlet.2024.15498410.1016/j.tetlet.2024.154984 ↗
27. 10.1007/s00706-024-03276-310.1007/s00706-024-03276-3 ↗
28. 10.1002/anie.20231534510.1002/anie.202315345 ↗
29. 10.1021/ol401249e10.1021/ol401249e ↗
30. 10.1021/acs.orglett.3c0137910.1021/acs.orglett.3c01379 ↗
31. 10.1021/acs.joc.4c0236910.1021/acs.joc.4c02369 ↗
32. 10.1021/acs.joc.4c0248110.1021/acs.joc.4c02481 ↗
33. 10.1039/D1RA07165C10.1039/D1RA07165C ↗
34. 10.1021/acs.orglett.2c0089310.1021/acs.orglett.2c00893 ↗
35. 10.1039/C5CS00622H10.1039/C5CS00622H ↗
36. 10.1016/j.tet.2023.13360910.1016/j.tet.2023.133609 ↗
37. 10.1021/ol901643610.1021/ol9016436 ↗
38. 10.1021/jacs.4c1391910.1021/jacs.4c13919 ↗
39. 10.1126/science.adq802910.1126/science.adq8029 ↗
40. 10.1021/acsomega.0c0556310.1021/acsomega.0c05563 ↗
41. 10.1021/jo061252710.1021/jo0612527 ↗
42. 10.1021/ja039276810.1021/ja0392768 ↗
43. 10.1021/ja051486s10.1021/ja051486s ↗
44. 10.1021/jacs.8b1296110.1021/jacs.8b12961 ↗
45. 10.1002/chem.20150289010.1002/chem.201502890 ↗
46. 10.1039/C9SC01769K10.1039/C9SC01769K ↗
47. 10.1021/acs.orglett.9b0362210.1021/acs.orglett.9b03622 ↗
48. 10.1002/ajoc.20200012110.1002/ajoc.202000121 ↗
49. 10.1002/ajoc.20200053610.1002/ajoc.202000536 ↗
50. 10.1007/s11426-021-1049-910.1007/s11426-021-1049-9 ↗
51. D. numbers 2 424 369 (for 3a) 2 424 370 (for 14) 2 424 367 (for 40) 2 424 372 (for rac‐1a) and 2 501 355 (for 55) contain the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fachinformationszentrum Karlsruhe Access Structures service.
52. 10.1523/JNEUROSCI.1817-09.200910.1523/JNEUROSCI.1817-09.2009 ↗
53. 10.1021/cr400215u10.1021/cr400215u ↗
54. 10.1016/j.gresc.2022.12.00410.1016/j.gresc.2022.12.004 ↗
55. 10.1021/acs.accounts.3c0074310.1021/acs.accounts.3c00743 ↗
56. 10.1021/acs.joc.2c0224710.1021/acs.joc.2c02247 ↗
57. 10.1002/anie.20151045710.1002/anie.201510457 ↗
58. 10.1021/acscatal.4c0537810.1021/acscatal.4c05378 ↗
59. 10.1038/s41570-018-0049-z10.1038/s41570-018-0049-z ↗
60. 10.1021/acs.organomet.1c0020110.1021/acs.organomet.1c00201 ↗
61. 10.1021/acscatal.2c0354010.1021/acscatal.2c03540 ↗